Literature DB >> 17475767

Age-specific salivary immunoglobulin A response to Streptococcus mutans GbpB.

Ruchele D Nogueira1, Alessandra C Alves, William F King, Reginaldo B Gonçalves, José F Höfling, Daniel J Smith, Renata O Mattos-Graner.   

Abstract

In a follow-up study of children infected with Streptococcus mutans at an early age (children previously shown to respond poorly to S. mutans GbpB), there was a delay in their immune response, rather than a complete inability to respond to this antigen. Epitopes in the N-terminal third of GbpB were identified as targets for naturally induced immunoglobulin A antibody in children at an early age.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17475767      PMCID： PMC1951079          DOI： 10.1128/CVI.00098-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  13 in total

Review 1.  Dental caries vaccines: prospects and concerns.

Authors:  D J Smith
Journal:  Crit Rev Oral Biol Med       Date:  2002

Review 2.  A Caries Vaccine? The state of the science of immunization against dental caries.

Authors:  Michael W Russell; Noel K Childers; Suzanne M Michalek; Daniel J Smith; Martin A Taubman
Journal:  Caries Res       Date:  2004 May-Jun       Impact factor: 4.056

3.  Genome of the opportunistic pathogen Streptococcus sanguinis.

Authors:  Ping Xu; Joao M Alves; Todd Kitten; Arunsri Brown; Zhenming Chen; Luiz S Ozaki; Patricio Manque; Xiuchun Ge; Myrna G Serrano; Daniela Puiu; Stephanie Hendricks; Yingping Wang; Michael D Chaplin; Doruk Akan; Sehmi Paik; Darrell L Peterson; Francis L Macrina; Gregory A Buck
Journal:  J Bacteriol       Date:  2007-02-02       Impact factor: 3.490

4.  Cloning of the Streptococcus mutans gene encoding glucan binding protein B and analysis of genetic diversity and protein production in clinical isolates.

Authors:  R O Mattos-Graner; S Jin; W F King; T Chen; D J Smith; M J Duncan
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

5.  Isotype, subclass and molecular size of immunoglobulins in salivas from young infants.

Authors:  D J Smith; W F King; M A Taubman
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

6.  Immunogenicity and protective immunity induced by synthetic peptides associated with putative immunodominant regions of Streptococcus mutans glucan-binding protein B.

Authors:  Daniel J Smith; William F King; Leigh A Barnes; Zachary Peacock; Martin A Taubman
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

7.  Purification and antigenicity of a novel glucan-binding protein of Streptococcus mutans.

Authors:  D J Smith; H Akita; W F King; M A Taubman
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  Association of salivary immunoglobulin A antibody and initial mutans streptococcal infection.

Authors:  D J Smith; W F King; H Akita; M A Taubman
Journal:  Oral Microbiol Immunol       Date:  1998-10

9.  The role of a human antigen specific T8+ cell subset in antigen presentation, helper function and contrasuppression.

Authors:  T Lehner; J Avery; T Jones
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

10.  The oral gram-negative anaerobic microflora in young children: longitudinal changes from edentulous to dentate mouth.

Authors:  E Könönen; S Asikainen; M Saarela; J Karjalainen; H Jousimies-Somer
Journal:  Oral Microbiol Immunol       Date:  1994-06
View more
  2 in total

1.  Downregulation of GbpB, a component of the VicRK regulon, affects biofilm formation and cell surface characteristics of Streptococcus mutans.

Authors:  Cristiane Duque; Rafael N Stipp; Bing Wang; Daniel J Smith; José F Höfling; Howard K Kuramitsu; Margaret J Duncan; Renata O Mattos-Graner
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Mutans streptococcal infection induces salivary antibody to virulence proteins and associated functional domains.

Authors:  R D Nogueira; W F King; G Gunda; S Culshaw; M A Taubman; R O Mattos-Graner; D J Smith
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.